Defence Therapeutics Inc. (DTCFF)
USD 0.62
(3.69%)
USD 0.62
(3.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -12.67 Million CAD | -95.59% |
| 2023 | -6.48 Million CAD | 11.18% |
| 2022 | - CAD | -155.18% |
| 2021 | - CAD | -324.74% |
| 2020 | - CAD | -1504.72% |
| 2019 | - CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.08 Million CAD | -20.75% |
| 2024 Q2 | -8.3 Million CAD | -295.27% |
| 2024 Q3 | -1.18 Million CAD | 85.34% |
| 2024 Q4 | -1.13 Million CAD | 4.93% |
| 2023 Q4 | -1.72 Million CAD | -39.77% |
| 2023 Q3 | -1.23 Million CAD | 35.02% |
| 2023 Q2 | -1.9 Million CAD | -14.25% |
| 2023 FY | - CAD | 10.48% |
| 2023 Q1 | -1.66 Million CAD | 23.19% |
| 2022 Q1 | -1.52 Million CAD | 9.19% |
| 2022 Q3 | -1.67 Million CAD | 13.59% |
| 2022 Q4 | -2.16 Million CAD | -29.11% |
| 2022 FY | - CAD | -155.18% |
| 2022 Q2 | -1.94 Million CAD | -26.87% |
| 2021 Q3 | -690.74 Thousand CAD | -56.19% |
| 2021 FY | - CAD | -324.74% |
| 2021 Q1 | -41.5 Thousand CAD | 91.2% |
| 2021 Q4 | -1.68 Million CAD | -143.9% |
| 2021 Q2 | -442.25 Thousand CAD | -965.55% |
| 2020 Q3 | -192.27 Thousand CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 FY | - CAD | -1504.72% |
| 2020 Q4 | -471.5 Thousand CAD | -145.23% |
| 2019 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bioxytran, Inc. | -3.82 Million USD | -231.814% |
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 82.156% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -5200.348% |
| SQZ Biotechnologies Company | -64.14 Million USD | 80.238% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -379.336% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 27.025% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 113.479% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -725.22% |
| Marizyme, Inc. | -34.28 Million USD | 63.024% |
| Genus plc | 73.7 Million USD | 117.199% |
| Pharming Group N.V. | 9.87 Million USD | 228.336% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -752.204% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -257.366% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -44.503% |
| ContraFect Corporation | -64.99 Million USD | 80.498% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -804.245% |
| IMV Inc. | -35.52 Million USD | 64.317% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -445.472% |
| ONE Bio Corp. | 13.61 Million USD | 193.115% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 73.716% |
| Mesoblast Limited | -62.38 Million USD | 79.683% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -2346.845% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 454.865% |
| Genscript Biotech Corporation | -248.71 Million USD | 94.904% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -1904.374% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -454.863% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -113.796% |
| Biomind Labs Inc. | -1.03 Million USD | -1125.247% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -338.256% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -77.005% |
| Skye Bioscience, Inc. | -13.54 Million USD | 6.435% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 188615.497% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -91.723% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -50603.128% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -180.054% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -226.332% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 20.126% |
| Accustem Sciences Inc. | -3.74 Million USD | -238.344% |
| EV Biologics, Inc. | -1.26 Million USD | -900.352% |
| Q BioMed Inc. | -617.62 Thousand USD | -1952.333% |
| GB Sciences, Inc. | -1.41 Million USD | -792.733% |
| Alpha Cognition Inc. | -9.7 Million USD | -30.603% |
| CSL Limited | 4.78 Billion USD | 100.265% |
| Agentix Corp. | -1.37 Million USD | -824.055% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 68.02% |
| Enzolytics Inc. | -2.12 Million USD | -497.343% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Resverlogix Corp. | -11.74 Million USD | -7.952% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -313.833% |
| MetaStat, Inc. | - USD | Infinity% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -406.634% |
| argenx SE | -216.02 Million USD | 94.132% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 77.094% |
| HST Global, Inc. | -5303.00 USD | -238930.398% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 1141.56% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -516.227% |
| Halberd Corporation | -74.27 Thousand USD | -16965.095% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 243.168% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 3445.911% |
| Zenith Capital Corp. | -8.6 Million USD | -47.29% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -745.669% |
| GeneThera, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -418.127% |
| AVAX Technologies, Inc. | -6.11 Million USD | -107.37% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -7101.152% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -559.884% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -72661.506% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -1.03 Million USD | -1124.953% |
| Helix BioMedix, Inc. | -1.04 Million USD | -1111.472% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -624.331% |
| Kadimastem Ltd | -2.62 Million USD | -383.001% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| BioStem Technologies, Inc. | -7.55 Million USD | -67.81% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -6899.791% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| LadRx Corporation | 412.28 Thousand USD | 3174.534% |
| Cell Source, Inc. | -4.27 Million USD | -196.681% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -3351.813% |
| Regen BioPharma, Inc. | 1.46 Million USD | 964.677% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -1252.879% |
| Affymax, Inc. | -14.29 Million USD | 11.327% |
| Mobile Lads Corp. | -2.24 Million USD | -465.59% |
| Itoco Inc. | -1.86 Million USD | -578.214% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -3239.071% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -1035.823% |
| International Stem Cell Corporation | 202 Thousand USD | 6375.14% |
| CytoDyn Inc. | -18.02 Million USD | 29.692% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -15939.406% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -103553.463% |
| Qrons Inc. | -40.08 Thousand USD | -31525.414% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -2509.915% |
| SYBLEU INC | -141.57 Thousand USD | -8853.657% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 2503.297% |
| Rebus Holdings, Inc. | -951 Thousand USD | -1232.89% |
| GlobeImmune, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -1093.565% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -23980.133% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -414.871% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 64.661% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -28068.404% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -362.958% |
| Neutra Corp. | -181.24 Thousand USD | -6893.651% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 37.121% |
| PureTech Health plc | -11.62 Million USD | -9.02% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 37.117% |
| IXICO plc | -707 Thousand USD | -1692.897% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -64.942% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 73.781% |
| CSL Limited | 4.73 Billion USD | 100.268% |
| Cellectis S.A. | -92.63 Million USD | 86.317% |